It promotes GBM progression in a mouse model of in situ glioma in which the loss of function of IDH3α not only reduces TCA activity but also promotes methionine cycle activity, S-adenosylmethionine production, and DNA methylation [68]. Here, IDH3A is linked to glioblastoma.